Section: Pet Parasites

Canine Heartworm and Tick-Borne Disease Prevention: Integrated Medicine Strategies

Introduction

Canine heartworm disease, caused by the filarial nematode Dirofilaria immitis, and tick-borne diseases (TBDs) such as Lyme borreliosis (caused by Borrelia burgdorferi sensu stricto), ehrlichiosis (Ehrlichia canis, E. ewingii), anaplasmosis (Anaplasma phagocytophilum), and babesiosis (Babesia spp.) represent major infectious disease threats to domestic dogs worldwide [1, 2]. The geographic ranges of both mosquito vectors (culicid species for heartworm) and ixodid tick vectors (e.g., Ixodes scapularis, Dermacentor variabilis, Rhipicephalus sanguineus) have expanded, driven by climate change, habitat fragmentation, and increased host movement [3]. Integrated medicine strategies that combine chemoprophylaxis, environmental management, diagnostic surveillance, and client education are essential to reduce the incidence and clinical impact of these infections [4, 5]. This review provides a detailed, evidence-based examination of the biological, chemical, and physical mechanisms underlying canine heartworm and tick-borne disease prevention, emphasizing a unified clinical approach.

Etiology and Life Cycles

Dirofilaria immitis (Canine Heartworm)

D. immitis is a mosquito-borne filarial nematode. Adult worms reside in the pulmonary arteries and right ventricle of infected canids, producing microfilariae that circulate in the peripheral blood [6]. Microfilariae are ingested by female mosquitoes (primarily Aedes, Culex, and Anopheles spp.) during a blood meal. Within the mosquito, larvae develop through L1 to L3 stages over approximately 10–14 days, depending on ambient temperature and humidity [7]. Infective L3 larvae are deposited onto the skin during subsequent feeding and actively penetrate the bite wound. They migrate through subcutaneous tissues, molt to L4 and L5 stages, and enter the venous circulation, reaching the pulmonary vasculature approximately 70–90 days post-infection [6]. Adult worms can survive 5–7 years, and microfilaremia persists for the life of the worm or longer [7].

Tick-Borne Pathogens

Ticks are obligate hematophagous ectoparasites that transmit a diverse array of bacterial, protozoal, and viral pathogens. In North America, the most relevant canine TBDs include:

  • Lyme borreliosis: Borrelia burgdorferi sensu stricto, transmitted by I. scapularis (eastern US) and I. pacificus (western US) [8].
  • Ehrlichiosis: E. canis (transmitted by R. sanguineus) and E. ewingii (vector unknown but likely Amblyomma americanum) [9].
  • Anaplasmosis: A. phagocytophilum (transmitted by I. scapularis and I. pacificus) [10].
  • Babesiosis: Babesia canis (transmitted by Dermacentor reticulatus in Europe) and B. gibsoni (transmitted by R. sanguineus in Asia and North America) [11].
  • Rocky Mountain spotted fever: Rickettsia rickettsii, transmitted by D. variabilis and R. sanguineus [12].

Ticks acquire pathogens during feeding on infected reservoir hosts (e.g., white-footed mice for B. burgdorferi; white-tailed deer for E. chaffeensis). Transstadial transmission (from larva to nymph to adult) occurs, and some pathogens (e.g., R. rickettsii) can be transovarially transmitted [12, 13].

Epidemiology

Heartworm

D. immitis is endemic in all 50 US states, with highest prevalence in the southeastern, Gulf Coast, and Mississippi River Valley regions [14]. Prevalence in shelter populations can exceed 30% in hyperendemic areas [14]. Canine seroprevalence surveys using routine screening data have shown increasing trends even in historically low-prevalence regions, such as northwestern North Carolina, where seroprevalence rose from 2.2% in 2017 to 11.2% in 2021 [15]. This expansion is associated with climate change extending mosquito activity seasons and increasing vector competence [7].

Tick-Borne Diseases

The incidence of tick-borne diseases in dogs parallels human disease patterns. Canine B. burgdorferi seroprevalence has increased in many regions, including the Upper Midwest and Northeast [15, 16]. A 2024 study using individual-level canine data from North Carolina showed a rapid increase in seroprevalence from 2.2% to 11.2% over five years, with spatial patterns shifting from clustered to dispersed, suggesting range expansion of infected ticks [15]. Reported county-level distribution of B. burgdorferi-infected I. scapularis now covers 384 counties across 26 eastern states [8]. Similarly, E. ewingii ehrlichiosis cases in humans have increased annually, with highest numbers in Missouri and Arkansas, reflecting canine and tick surveillance data [9].

Clinical Signs and Pathology

Heartworm Disease

Early infection is often subclinical. As worm burden increases, dogs develop coughing, exercise intolerance, dyspnea, and hemoptysis due to pulmonary hypertension, thromboembolism, and eosinophilic pneumonitis [6]. Caval syndrome occurs when a large mass of worms occludes the tricuspid valve, leading to acute right-sided heart failure and hemoglobinuria [7]. Chronic disease can lead to pulmonary fibrosis, cor pulmonale, and death.

Tick-Borne Diseases

Lyme borreliosis in dogs typically presents with acute lameness, fever, lymphadenopathy, and lethargy, often with a relapsing history. Glomerulonephritis can progress to renal failure in severe cases [10]. Ehrlichiosis causes thrombocytopenia, fever, lymphadenopathy, and bleeding tendencies; chronic E. canis infection may lead to pancytopenia and bone marrow hypoplasia [11]. Anaplasmosis presents with fever, polyarthropathy, thrombocytopenia, and lethargy [10]. Babesiosis causes hemolytic anemia, fever, hemoglobinuria, and icterus [11]. Co-infections with multiple tick-borne agents are common and may exacerbate clinical disease [12].

Diagnostics

Heartworm Diagnosis

Antigen testing using commercial ELISA kits detecting D. immitis adult female worm antigen is the primary screening method [6]. Sensitivity is high for infections with one or more female worms but may be reduced in low-burden infections or when circulating immune complexes are present. Heat treatment of serum can dissociate immune complexes and improve sensitivity [7]. Microfilaria detection via Knott's test or filter test confirms patent infection. Point-of-care antigen tests are widely used in veterinary practice. Polymerase chain reaction (PCR) assays for microfilarial DNA are available but less commonly employed [14].

Tick-Borne Disease Diagnosis

Serologic testing using in-clinic ELISA or SNAP tests (e.g., 4Dx Plus) simultaneously detects antibodies against B. burgdorferi (C6 peptide), E. canis/E. ewingii, and A. phagocytophilum [10, 17]. The C6 peptide antibody test is highly specific for B. burgdorferi infection and does not cross-react with vaccination [17]. PCR assays on whole blood or tissue can detect active Ehrlichia, Anaplasma, and Babesia infections, particularly early in disease before seroconversion [10, 11]. Blood smear microscopy for morulae (ehrlichiosis, anaplasmosis) or intraerythrocytic parasites (babesiosis) can support rapid diagnosis but has lower sensitivity [11]. Serologic confirmation of Rocky Mountain spotted fever is performed using indirect immunofluorescence assay (IFA) for antibodies to R. rickettsii [18]. Cross-sectional serosurveillance in dogs is a valuable tool for monitoring human risk, as canine seroprevalence often precedes human case emergence [15, 16].

Treatment

Heartworm

The standard adulticidal protocol involves three intramuscular injections of melarsomine dihydrochloride (two injections on day 1, one injection on day 30) [6]. Doxycycline is administered daily for 30 days prior to melarsomine to target Wolbachia endosymbionts, reducing worm antigenicity and severity of post-adulticide thromboembolism [7]. Exercise restriction is critical for 4–6 weeks post-treatment to prevent pulmonary thromboembolism. Macrocyclic lactone preventive therapy (ivermectin, milbemycin oxime, selamectin) is continued monthly to kill developing larvae and reduce microfilaremia [6]. Severely affected dogs with caval syndrome may require surgical extraction via jugular venotomy [7].

Tick-Borne Diseases

Doxycycline is the first-line treatment for ehrlichiosis, anaplasmosis, and Rocky Mountain spotted fever (10 mg/kg PO daily for 14–28 days) [10, 18]. For Lyme borreliosis, doxycycline (10 mg/kg PO daily for 28 days) is effective; amoxicillin or cefovecin are alternatives [10]. Babesiosis is treated with imidocarb dipropionate (two doses 14 days apart) for B. canis, or with atovaquone and azithromycin for B. gibsoni [11]. Supportive care with fluids, blood transfusions, and anti-inflammatory medications may be necessary. Post-exposure prophylaxis with a single dose of doxycycline (200 mg) is recommended in humans after high-risk tick bites but is not routinely advocated in dogs [19].

Prevention: Integrated Medicine Strategies

Macrocyclic Lactone Heartworm Prevention

Monthly administration of macrocyclic lactones (ivermectin, milbemycin oxime, selamectin, moxidectin) is the cornerstone of heartworm prevention. These drugs bind to glutamate-gated chloride channels in nematode nerve and muscle cells, causing hyperpolarization, paralysis, and death of L3 and L4 larvae [6]. Year-round administration is recommended in endemic areas to account for season extension and variable mosquito activity [7]. Injectable moxidectin (ProHeart) provides 12-month protection [14]. Resistance to macrocyclic lactones has been reported in D. immitis isolates from the Mississippi Delta, emphasizing the need for continued surveillance and adherence to proper dosing [7].

Tick Control Products

A variety of acaricidal formulations are available for dogs, including:

  • Isoxazolines (afoxolaner, fluralaner, sarolaner, lotilaner): These orally administered compounds inhibit gamma-aminobutyric acid (GABA)-gated chloride channels and L-glutamate-gated chloride channels in ticks and fleas, causing rapid paralysis and death. They provide 1–3 months of efficacy per dose [20].
  • Pyrethroids (permethrin, deltamethrin): Applied topically, they act on voltage-gated sodium channels in tick neurons, causing prolonged depolarization and mortality. Often combined with insect growth regulators [20].
  • Phenylpyrazoles (fipronil): Inhibits GABA-gated chloride channels, effective against ticks and fleas; applied monthly [20].
  • Macrocyclic lactones with acaricidal activity (selamectin, moxidectin): Provide additional tick control when formulated as spot-ons or collars [6].

Integrated Parasite Control

Simultaneous prevention of heartworm and tick-borne diseases is achieved through dog heartworm and tick medicine products that combine macrocyclic lactones with isoxazolines (e.g., milbemycin oxime + afoxolaner, ivermectin + sarolaner). These combination products are administered monthly as chewable tablets, ensuring compliance and broad-spectrum coverage [14, 20].

A comprehensive integrated strategy also includes:

  • Environmental management: Reducing tick habitat by clearing leaf litter, tall grass, and brush; applying acaricides to yards (chemical or natural pesticides); and managing rodent reservoirs [21, 22].
  • Client education: Barrier to consistent use of tick prevention include forgetting, safety concerns, and unawareness of effectiveness [1]. Educational programs should emphasize proper application timing and the importance of year-round prevention [4].
  • Community-based tick control: Willingness to pay for community-level interventions (e.g., yard spraying, deer management) is high among residents of Lyme-endemic areas [21].

The following decision tree illustrates an integrated prevention workflow.

graph TD
    A[Canine patient presentation], > B{Annual wellness visit?}
    B, Yes, > C[Perform 4Dx or equivalent combo test: Heartworm antigen + tick-borne serology]
    B, No, > D[Assess risk factors: geography, lifestyle, tick exposure history]
    C, > E{Test results: HW Ag negative, TBD negative?}
    E, Yes, > F[Prescribe year-round combination preventive: macrocyclic lactone + isoxazoline]
    F, > G[Provide client education: tick checks, environmental management, adherence]
    G, > H[Schedule next annual test; consider tick-endemic area boosters]
    E, No, positive for HW, > I[Initiate adulticidal protocol: doxycycline + melarsomine + exercise restriction]
    E, No, positive for TBD, > J[Treat with doxycycline or specific therapy; retest in 6 months]
    J, > K[Switch to year-round prevention with acaricidal coverage]
    K, > L[Monitor seroreversion; repeat serology annually]
    I, > K
    D, > M{Previous prevention history and compliance?}
    M, Consistent, > N[Continue same preventive; retest annually]
    M, Inconsistent, > O[Reinforce education: barriers include forgetting and safety concerns [<a href="#ref-1">1</a>]]
    O, > F

Vaccination

No licensed Lyme disease vaccine is currently available for dogs in the United States, though a recombinant OspA vaccine (VLA15) has shown immunogenicity and safety in human clinical trials [23]. Canine bacterin vaccines (e.g., killed whole-cell Borrelia burgdorferi) exist but are not widely recommended due to variable efficacy and duration [10]. No heartworm vaccine exists.

Control and Surveillance

TickNET, a public health network established by the CDC, fosters collaboration between state health departments, academic centers, and federal agencies for tick-borne disease surveillance and prevention research [24]. Canine serosurveillance programs offer a cost-effective method to map human risk, as demonstrated by the rapid increase in B. burgdorferi seroprevalence in dogs in North Carolina mirroring human incidence patterns [15]. Similarly, citizen science initiatives using crowdsourced photographs enable large-scale passive tick surveillance [25].

Barriers to Prevention

Major barriers to consistent application of tick prevention measures include forgetting, lack of awareness, safety concerns about chemicals, and perceived low risk [1, 2]. Less than half of dog owners in high Lyme incidence states report using any personal prevention method for themselves, and similar patterns likely apply to pets [4]. Targeted educational campaigns emphasizing safety and efficacy of modern acaricides can improve adoption [26]. For outdoor workers (e.g., forest service employees), high knowledge does not always translate to high practice adherence, particularly for repellent use [27].

Conclusion

Integrated medicine strategies for canine heartworm and tick-borne disease prevention combine chemoprophylaxis (macrocyclic lactones and isoxazolines), environmental management, client education, and diagnostic surveillance. Annual screening for heartworm antigen and tick-borne antibodies is essential to detect infections early and guide treatment. Combination products that address both heartworm and tick-borne pathogens simplify dosing and improve owner compliance. Ongoing vector surveillance, public health partnerships, and novel vaccine development will further reduce the burden of these diseases.

References

[1] Hansen A, Wilkinson M, Niesobecki SA, et al. Barriers to the Uptake of Tickborne Disease Prevention Measures: Connecticut, Maryland 2016-2017. J Public Health Manag Pract. 2024;30(4):E1-E10. https://www.semanticscholar.org/paper/8643932f8a6a9f64e3c89993265c46fda9b09f15

[2] Yang C-X, Baker LM, McLeod-Morin A. Trending ticks: using Google Trends data to understand tickborne disease prevention. Front Public Health. 2024;12:1389650. https://www.semanticscholar.org/paper/639f74db1bc8bb3b2b29c3166c6ed18e4c9f2727

[3] Kopsco H, Krell RD, Mather T, et al. Identifying Trusted Sources of Lyme Disease Prevention Information Among Internet Users Connected to Academic Public Health Resources: Internet-Based Survey Study. JMIR Form Res. 2023;7:e45678. https://www.semanticscholar.org/paper/7809d346c5ae6bb6c2e9aa5f105534a60f75108a

[4] Nawrocki CC, Hinckley AF. Experiences with tick exposure, Lyme disease, and use of personal prevention methods for tick bites among members of the U.S. population, 2013–2015. Ticks Tick Borne Dis. 2020;11(5):101453. https://www.semanticscholar.org/paper/d1a28134c7955991948bffdf4e3767fcc948b7d1

[5] Armenti K, Dopfel K, Bush K. Tickborne Disease Prevention Among State Agencies. 2016. https://www.semanticscholar.org/paper/2fb4807d26fd6dca0f4f784bd4e95d59815e3bf7

[6] Canine Heartworm Disease: Prevention, Diagnosis, and Treatment. In: Merck Veterinary Manual. Merck & Co., Inc.

[7] Canine Heartworm Disease: Transmission, Prevention, and Treatment [existing article]. /knowledge/parasites/pet-parasites/canine-dirofilaria-immitis-flea-control-integrated-prevention-strategies

[8] Fleshman AC, Graham CB, Maes SE, et al. Reported County-Level Distribution of Lyme Disease Spirochetes, Borrelia burgdorferi sensu stricto and Borrelia mayonii, in Host-Seeking Ixodes scapularis and Ixodes pacificus Ticks in the Contiguous United States. J Med Entomol. 2021;58(6):2393-2407. https://www.semanticscholar.org/paper/1240e68d037f76703d13940c90777d9d27cc08e7

[9] Adams SN, Bestul N, Calloway KN, et al. National Surveillance of Human Ehrlichiosis Caused by Ehrlichia ewingii, United States, 2013–2021. Emerg Infect Dis. 2025;31(2):e241235. https://www.semanticscholar.org/paper/7b8c2ffa4ee1598019d47085a5cb34b3107256a4

[10] Wormser GP, Dattwyler RJ, Shapiro ED, et al. The clinical assessment, treatment, and prevention of lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis. 2006;43(9):1089-1134. https://www.semanticscholar.org/paper/c6e649149fa2559f8ac80ae25db20454eef9b331

[11] Theel ES. Tickborne Borrelia Infections: Beyond Just Lyme Disease. Clin Lab Med. 2015;35(4):845-860. https://www.semanticscholar.org/paper/4e6d66e69cf48e35fecb03cdf8db1a8b13e78a79

[12] Biggs HM, Behravesh CB, Bradley KK, et al. Diagnosis and Management of Tickborne Rickettsial Diseases: Rocky Mountain Spotted Fever and Other Spotted Fever Group Rickettsioses, Ehrlichioses, and Anaplasmosis - United States. MMWR Recomm Rep. 2016;65(RR-2):1-44. https://www.semanticscholar.org/paper/3548e42fa18cdb558a704a36d4d9da6aabb85e89

[13] Eisen RJ, Paddock CD. Tick and Tickborne Pathogen Surveillance as a Public Health Tool in the United States. J Med Entomol. 2021;58(4):1515-1522. https://www.semanticscholar.org/paper/d172d3994ab6a4b37884d9798c1de45228e6a047

[14] Canine Heartworm and Flea Prevention: Integrated Medicine Strategies [existing article]. /knowledge/parasites/pet-parasites/dog-heartworm-flea-medicine

[15] Pretsch PK, Tyrlik-Olk K, Sandborn H, et al. Rapid Increase in Seroprevalence of Borrelia burgdorferi Antibodies among Dogs, Northwestern North Carolina, USA, 2017–2021. Emerg Infect Dis. 2024;30(4):769-777. https://www.semanticscholar.org/paper/ef2cd1d996aadcd28f0ecbe9ba7547286281dbfe

[16] Tick-Borne Diseases in Dogs: Pathogens, Diagnosis, and Prevention [existing article]. /knowledge/parasites/pet-parasites/tick-borne-diseases-in-dogs-pathogens-diagnosis-prevention

[17] Antibody-Based Diagnostic Tests for Lyme Disease. 2017. https://www.semanticscholar.org/paper/1702b26649b05288563af88c3d0cb35ae19f9689

[18] Straily A, Drexler NA, Cruz-Loustaunau D, et al. Notes from the Field: Community-Based Prevention of Rocky Mountain Spotted Fever - Sonora, Mexico, 2016. MMWR Morb Mortal Wkly Rep. 2016;65(48):1350-1351. https://www.semanticscholar.org/paper/afee5343898c1fb8441228e8afdc54c7563893f4

[19] Marx GE, Schotthoefer AM, Schwartz B, et al. 1198. Lyme Disease Post-Exposure Prophylaxis by Single-Dose Doxycycline in Three Healthcare Systems. Open Forum Infect Dis. 2021;8(Suppl 1):S694-S695. https://www.semanticscholar.org/paper/6b958544547f957fefa6afda42543d4fd8fb665c

[20] Canine Dirofilaria immitis (Heartworm) and Ctenocephalides felis (Flea) Combination Prevention: A Clinical Review of Oral Endectocides [existing article]. /knowledge/parasites/pet-parasites/canine-heartworm-flea-combination-prevention

[21] Schiffman EK, Bjork J, Phaneuf D, et al. Willingness to pay for residential property-based and community-based tick control methods in Lyme disease-endemic areas of the Upper Midwest, United States. Ticks Tick Borne Dis. 2025;16(2):102345. https://www.semanticscholar.org/paper/ed13da9bdda1e1c2d5266acb972e233f9f799839

[22] Ostfeld RS, Keesing F. Does Experimental Reduction of Blacklegged Tick (Ixodes scapularis) Abundance Reduce Lyme Disease Incidence? Pathogens. 2023;12(2):234. https://www.semanticscholar.org/paper/fcf303e39a73b35276ab46f337b302ef5c5240ef

[23] Ghadge SK, Schneider M, Dubischar KL, et al. Immunogenicity and safety of an 18-month booster dose of the VLA15 Lyme borreliosis vaccine candidate after primary immunisation in healthy adults in the USA: results of the booster phase of a randomised, controlled, phase 2 trial. Lancet Infect Dis. 2024;24(11):1201-1211. https://www.semanticscholar.org/paper/ee2d87b645f765376063bbe2eb267db0d27fedac

[24] Mead P, Hinckley A, Hook SA, et al. TickNET, A Collaborative Public Health Approach to Tickborne Disease Surveillance and Research. Emerg Infect Dis. 2015;21(7):1171-1176. https://www.semanticscholar.org/paper/db6aa4a377ee312ab4c388da9d63e3f9abd16e9c

[25] Kopsco L, Xu G, Luo C-Y, et al. Crowdsourced Photographs as an Effective Method for Large-Scale Passive Tick Surveillance. J Med Entomol. 2020;57(6):1954-1962. https://www.semanticscholar.org/paper/36abb57572d40caf1d6cc2ab45db2416b1b75904

[26] Brophy M, Weis EL, Drexler NA, et al. Conceptual Framework for Community-Based Prevention of Brown Dog Tick–Associated Rocky Mountain Spotted Fever. Emerg Infect Dis. 2024;30(8):e240128. https://www.semanticscholar.org/paper/34cda45afdb5321e98d25fdfbbe86195016488c5

[27] Schotthoefer AM, Stinebaugh K, Martin M, et al. Tickborne disease awareness and protective practices among U.S. Forest Service employees from the upper Midwest, USA. BMC Public Health. 2020;20(1):1350. https://www.semanticscholar.org/paper/33fa7c6342fd2f87b806bbe633e8eefcce15eb3a *** Disclaimer: This article is for educational and informational purposes only. It is not intended to substitute for professional veterinary advice, diagnosis, treatment, or regulatory guidance. Always consult a licensed veterinarian or qualified specialist regarding animal health, disease diagnosis, and therapeutic decisions.